Universe Pharmaceuticals (UPC) Interest & Investment Income (2022 - 2023)
Universe Pharmaceuticals' (UPC) quarterly Interest & Investment Income came in at $166931.0 in Q1 2023, down 76.03% year-on-year from $696430.0 in Q1 2022, and down 76.03% quarter-over-quarter from $696430.0 in Q1 2022.
Universe Pharmaceuticals (UPC) Interest & Investment Income (2022 - 2023) Analysis & Trends
Universe Pharmaceuticals has disclosed Interest & Investment Income across 2 years of filings, most recently posting $166931.0 for Q1 2023.
- Interest & Investment Income for Q1 2023 came in at $166931.0, down 76.03% year-over-year; the trailing twelve-month figure through Mar 2023 was $166931.0 (down 76.03% YoY), and the FY2023 annual result was $38530.0, up 108.19% from the prior year.
- Interest & Investment Income came in at $166931.0 for Q1 2023 at Universe Pharmaceuticals, down from $696430.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $696430.0 in Q1 2022 to a low of $166931.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Universe Pharmaceuticals | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 166,931.00 |
| Mar 31, 2022 | 696,430.00 |